Cargando…
Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528471/ https://www.ncbi.nlm.nih.gov/pubmed/34697607 http://dx.doi.org/10.1016/S2665-9913(21)00320-9 |
| _version_ | 1784586257673748480 |
|---|---|
| author | Sciascia, Savino Costanzo, Piera Radin, Massimo Schreiber, Karen Pini, Massimo Vaccarino, Antonella Cecchi, Irene Baldovino, Simone Roccatello, Dario |
| author_facet | Sciascia, Savino Costanzo, Piera Radin, Massimo Schreiber, Karen Pini, Massimo Vaccarino, Antonella Cecchi, Irene Baldovino, Simone Roccatello, Dario |
| author_sort | Sciascia, Savino |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8528471 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85284712021-10-21 Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies Sciascia, Savino Costanzo, Piera Radin, Massimo Schreiber, Karen Pini, Massimo Vaccarino, Antonella Cecchi, Irene Baldovino, Simone Roccatello, Dario Lancet Rheumatol Correspondence Elsevier Ltd. 2021-12 2021-10-20 /pmc/articles/PMC8528471/ /pubmed/34697607 http://dx.doi.org/10.1016/S2665-9913(21)00320-9 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Sciascia, Savino Costanzo, Piera Radin, Massimo Schreiber, Karen Pini, Massimo Vaccarino, Antonella Cecchi, Irene Baldovino, Simone Roccatello, Dario Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies |
| title | Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies |
| title_full | Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies |
| title_fullStr | Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies |
| title_full_unstemmed | Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies |
| title_short | Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies |
| title_sort | safety and tolerability of mrna covid-19 vaccines in people with antiphospholipid antibodies |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528471/ https://www.ncbi.nlm.nih.gov/pubmed/34697607 http://dx.doi.org/10.1016/S2665-9913(21)00320-9 |
| work_keys_str_mv | AT sciasciasavino safetyandtolerabilityofmrnacovid19vaccinesinpeoplewithantiphospholipidantibodies AT costanzopiera safetyandtolerabilityofmrnacovid19vaccinesinpeoplewithantiphospholipidantibodies AT radinmassimo safetyandtolerabilityofmrnacovid19vaccinesinpeoplewithantiphospholipidantibodies AT schreiberkaren safetyandtolerabilityofmrnacovid19vaccinesinpeoplewithantiphospholipidantibodies AT pinimassimo safetyandtolerabilityofmrnacovid19vaccinesinpeoplewithantiphospholipidantibodies AT vaccarinoantonella safetyandtolerabilityofmrnacovid19vaccinesinpeoplewithantiphospholipidantibodies AT cecchiirene safetyandtolerabilityofmrnacovid19vaccinesinpeoplewithantiphospholipidantibodies AT baldovinosimone safetyandtolerabilityofmrnacovid19vaccinesinpeoplewithantiphospholipidantibodies AT roccatellodario safetyandtolerabilityofmrnacovid19vaccinesinpeoplewithantiphospholipidantibodies |